|
DE69837903T2
(de)
|
1997-08-11 |
2008-02-14 |
Pfizer Products Inc., Groton |
Feste pharmazeutische Dispersionen mit erhöhter Bioverfügbarkeit
|
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
WO2001045677A1
(en)
*
|
1999-12-20 |
2001-06-28 |
Kerkhof Nicholas J |
Process for producing nanometer particles by fluid bed spray-drying
|
|
US8771740B2
(en)
*
|
1999-12-20 |
2014-07-08 |
Nicholas J. Kerkhof |
Process for producing nanoparticles by spray drying
|
|
US6316029B1
(en)
*
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
EP1186347A1
(de)
*
|
2000-09-05 |
2002-03-13 |
F. Hoffmann-La Roche Ag |
Verfahren und Vorrichtung zum Zerstäuben von Flüssigkeiten
|
|
WO2003013683A1
(en)
|
2001-08-08 |
2003-02-20 |
Brown University Research Foundation |
Methods for micronization of hydrophobic drugs
|
|
PL368346A1
(en)
*
|
2001-10-10 |
2005-03-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Powder processing with pressurized gaseous fluids
|
|
ES2341645T3
(es)
*
|
2001-11-30 |
2010-06-24 |
Life Technologies Corporation |
Medios para cultivo celular.
|
|
IL162183A0
(en)
*
|
2001-12-21 |
2005-11-20 |
Celator Technologies Inc |
Polymer-lipid delivery vehicles and methods for the preparation thereof
|
|
US20070059358A1
(en)
*
|
2003-07-02 |
2007-03-15 |
Tianjin Tasly Pharmaceutical Co., Ltd., China |
Matrix adjuvants and the drop pills prepared with them
|
|
US7198653B2
(en)
|
2003-07-31 |
2007-04-03 |
Delavau Llc |
Calcium carbonate granulation
|
|
US8188067B2
(en)
|
2004-04-01 |
2012-05-29 |
Teva Pharmaceutical Industries Ltd. |
Formulations of 6-mercaptopurine
|
|
AU2005232583B2
(en)
*
|
2004-04-01 |
2009-03-12 |
Teva Pharmaceutical Industries Ltd. |
Delayed release formulations of 6-mercaptopurine
|
|
RU2412191C2
(ru)
*
|
2004-07-16 |
2011-02-20 |
Лек Фармасьютиклз Д.Д. |
Продукты окислительной деструкции кальций аторвастатина
|
|
KR20070057901A
(ko)
*
|
2004-10-01 |
2007-06-07 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
미립자 함유 조성물 및 그의 제조 방법
|
|
ES2644450T3
(es)
*
|
2004-12-31 |
2017-11-29 |
Dr. Reddy's Laboratories Ltd. |
Nuevos derivados de bencilamina como inhibidores de CETP
|
|
US8604055B2
(en)
|
2004-12-31 |
2013-12-10 |
Dr. Reddy's Laboratories Ltd. |
Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
|
|
NZ556709A
(en)
|
2005-02-10 |
2009-09-25 |
Glaxo Group Ltd |
Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
|
|
DE102005011786A1
(de)
|
2005-03-11 |
2006-09-14 |
Pharmasol Gmbh |
Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
|
|
EP1895982A2
(en)
*
|
2005-05-05 |
2008-03-12 |
Sanofi-Aventis U.S. LLC |
Stable nanoparticle formulations
|
|
MX336930B
(es)
|
2005-11-28 |
2016-02-05 |
Marinus Pharmaceuticals |
Formulaciones de ganaxolona y metodos para la manufactura y el uso de las mismas.
|
|
JP2007297348A
(ja)
*
|
2006-05-02 |
2007-11-15 |
Daito Kk |
エバスチンを含有する錠剤
|
|
JP4204634B2
(ja)
*
|
2006-05-15 |
2009-01-07 |
株式会社荏原製作所 |
難水溶性医薬
|
|
JP2007306950A
(ja)
|
2006-05-15 |
2007-11-29 |
Osaka Univ |
薬効成分ナノ粒子分散液の製造方法
|
|
JP2009542648A
(ja)
*
|
2006-07-07 |
2009-12-03 |
テバ ファーマシューティカル インダストリーズ リミティド |
タダラフィル及び少なくとも1種の担体を含んでなる固体組成物
|
|
US9138414B1
(en)
|
2006-09-15 |
2015-09-22 |
Delavau Llc |
Calcium supplement having enhanced absorption
|
|
WO2008066899A2
(en)
|
2006-11-28 |
2008-06-05 |
Marinus Pharmaceuticals |
Nanoparticulate formulations and methods for the making and use thereof
|
|
US20080161594A1
(en)
*
|
2006-12-29 |
2008-07-03 |
Industrial Technology Research Institute |
Method for fabricating nanoparticles containing fenofibrate
|
|
JP2010526848A
(ja)
*
|
2007-05-11 |
2010-08-05 |
エフ.ホフマン−ラ ロシュ アーゲー |
難溶性薬物用の医薬組成物
|
|
DE102007028869A1
(de)
*
|
2007-06-22 |
2008-12-24 |
Ratiopharm Gmbh |
Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
|
|
FR2918277B1
(fr)
*
|
2007-07-06 |
2012-10-05 |
Coretecholding |
Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues
|
|
KR100991675B1
(ko)
*
|
2007-08-06 |
2010-11-04 |
한국식품연구원 |
식물 정유를 함유하는 나노에멀션과 나노입자 및 그제조방법
|
|
GB0720516D0
(en)
*
|
2007-10-18 |
2007-11-28 |
Cadbury Schweppes Plc |
Comestible products
|
|
FI121990B
(fi)
*
|
2007-12-20 |
2011-07-15 |
Beneq Oy |
Laite sumun ja hiukkasten tuottamiseksi
|
|
US20100055246A1
(en)
*
|
2008-08-28 |
2010-03-04 |
Dong June Ahn |
Nutrition delivery capsules for functional foods
|
|
US20100055187A1
(en)
*
|
2008-08-28 |
2010-03-04 |
Dong June Ahn |
Nanovitamin synthesis
|
|
GB0815852D0
(en)
*
|
2008-09-01 |
2008-10-08 |
Unilever Plc |
Improvements relating to pharmaceutical compositions
|
|
WO2010059506A1
(en)
*
|
2008-11-20 |
2010-05-27 |
Mallinckrodt Baker, Inc. |
Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient
|
|
CN102292072A
(zh)
|
2009-01-26 |
2011-12-21 |
特瓦制药工业有限公司 |
用微粒包衣载体的方法
|
|
EP2411137B1
(en)
|
2009-03-27 |
2016-09-07 |
Bend Research, Inc. |
Spray-drying process
|
|
PT2611530T
(pt)
|
2010-09-03 |
2019-05-09 |
Bend Res Inc |
Aparelho de secagem por pulverização e métodos de utilização do mesmo
|
|
WO2012031129A2
(en)
|
2010-09-03 |
2012-03-08 |
Bend Research, Inc. |
Spray-drying apparatus and methods of using the same
|
|
US8815294B2
(en)
|
2010-09-03 |
2014-08-26 |
Bend Research, Inc. |
Pharmaceutical compositions of dextran polymer derivatives and a carrier material
|
|
WO2012040502A1
(en)
|
2010-09-24 |
2012-03-29 |
Bend Research, Inc. |
High-temperature spray drying process and apparatus
|
|
KR20140006879A
(ko)
|
2011-02-17 |
2014-01-16 |
에프. 호프만-라 로슈 아게 |
고온 용융 압출에 의해 활성 약학 성분을 과냉된 액체 상태로부터 제어되는 방식으로 결정화시키는 방법
|
|
US9199967B2
(en)
|
2011-08-18 |
2015-12-01 |
Dr. Reddy's Laboratories Ltd. |
Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (CETP) inhibitors
|
|
EP2760864B1
(en)
|
2011-09-27 |
2018-01-24 |
Dr. Reddy's Laboratories Ltd. |
5-BENZYLAMINOMETHYL-6-AMINOPYRAZOLO[3,4-b]PYRIDINE DERIVATIVES AS CHOLESTERYL ESTER-TRANSFER PROTEIN (CETP) INHIBITORS USEFUL FOR THE TREATMENT OF ATHEROSCLEROSIS
|
|
US10076496B2
(en)
*
|
2011-11-11 |
2018-09-18 |
The Chinese University Of Hong Kong |
Engineering of polymer-stabilized nanoparticles for drugs with Log P values below 6 by controlled antisolvent precipitation
|
|
US9789071B2
(en)
|
2012-06-27 |
2017-10-17 |
G2B Pharma, Inc. |
Intranasal formulation of epinephrine for the treatment of anaphylaxis
|
|
EA035868B1
(ru)
*
|
2012-08-17 |
2020-08-24 |
Смартек Интернэшнл Эл-Эл-Си |
Приготовление высушенных липосом для применения в системах выпуска в прессованном виде
|
|
CA2891502A1
(en)
|
2012-11-19 |
2014-05-22 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical compositions of cetp inhibitors
|
|
CN104255715A
(zh)
*
|
2014-09-01 |
2015-01-07 |
李晓枫 |
一种纳米生物农药组合物及其制备方法
|
|
JP6650933B2
(ja)
|
2014-10-31 |
2020-02-19 |
ベンド リサーチ, インコーポレイテッド |
マトリックス中に分散された活性薬剤ドメインを形成するためのプロセス
|
|
AR106018A1
(es)
|
2015-08-26 |
2017-12-06 |
Achillion Pharmaceuticals Inc |
Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
|
|
WO2017035408A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Compounds for treatment of immune and inflammatory disorders
|
|
WO2017066619A1
(en)
|
2015-10-16 |
2017-04-20 |
Teva Pharmaceutical Industries Ltd. |
Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine
|
|
MX2018004376A
(es)
*
|
2015-10-16 |
2018-08-01 |
Marinus Pharmaceuticals Inc |
Formulaciones inyectables de neuroesteroides que contienen nanoparticulas.
|
|
WO2017117559A1
(en)
*
|
2015-12-30 |
2017-07-06 |
Life Technologies Corporation |
Layered cell culture particles and methods of making thereof
|
|
JP7057290B2
(ja)
|
2016-06-27 |
2022-04-19 |
アキリオン ファーマシューティカルズ,インコーポレーテッド |
医学的障害を治療するためのキナゾリン及びインドール化合物
|
|
KR102518846B1
(ko)
|
2016-08-11 |
2023-04-05 |
오비드 테라퓨틱스 인크. |
간질 장애의 치료를 위한 방법 및 조성물
|
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
|
DK3985002T3
(da)
|
2017-03-01 |
2025-08-18 |
Achillion Pharmaceuticals Inc |
Farmaceutiske aryl-, heteroaryl- og heterocyclylforbindelser til behandling af medicinske forstyrrelser
|
|
CN108586624A
(zh)
*
|
2018-05-15 |
2018-09-28 |
郑州轻工业学院 |
一种空气常压等离子体射流改性微晶淀粉的方法
|
|
JP7538113B2
(ja)
|
2018-08-20 |
2024-08-21 |
アキリオン ファーマシューティカルズ,インコーポレーテッド |
補体d因子の医学的障害の治療のための医薬化合物
|
|
WO2020051532A2
(en)
|
2018-09-06 |
2020-03-12 |
Achillion Pharmaceuticals, Inc. |
Macrocyclic compounds for the treatment of medical disorders
|
|
CN113365617B
(zh)
|
2018-10-16 |
2025-12-23 |
乔治亚州立大学研究基金会股份有限公司 |
用于医学疾病治疗的一氧化碳前药
|
|
US11266662B2
(en)
|
2018-12-07 |
2022-03-08 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of postpartum depression
|
|
CA3145923A1
(en)
|
2019-08-05 |
2021-02-11 |
David Czekai |
Ganaxolone for use in treatment of status epilepticus
|
|
AU2020395254A1
(en)
|
2019-12-06 |
2022-06-02 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in treating tuberous sclerosis complex
|
|
EP4603484A2
(en)
|
2019-12-19 |
2025-08-20 |
Georgia State University Research Foundation, Inc. |
Compounds for the treatment of bacterial infections and potentiation of antibiotics
|
|
JP2023515073A
(ja)
|
2020-02-20 |
2023-04-12 |
アキリオン ファーマシューティカルズ, インコーポレーテッド |
補体因子d媒介障害の処置用のヘテロアリール化合物
|
|
JP7787164B2
(ja)
|
2020-09-23 |
2025-12-16 |
アキリオン ファーマシューティカルズ, インコーポレーテッド |
補体媒介性障害の治療のための医薬化合物
|